- (2023). Beta2-adrenoreceptor agonists and long-term risk of Parkinson's disease. Parkinsonism & Related Disorders.
- (2023). An information-theoretic analysis of resting-state versus task fMRI. Network Neuroscience. 769-786.
- (2023). Drug-wide prospective study associates thirty-one drug classes with the risk of Parkinson’s disease.
- (2021). Definition of Parkinson's disease and estimation of its incidence based on nationwide prescription- and diagnostic data. Journal of the Neurological Sciences.